Issue #384
- Animal Retroviral Infections Suggest Third Kind of Potential Treatment: HIV Harm Reduction
- T-20 (FUZEON) Gets Priority Review
- ICAAC Clinical Trials Review Available
- Hepatitis C: FDA Public Meeting on Peginterferon Plus Ribavirin, Nov. 14
- Anti-HIV Factor Discovered
- Retroviruses Scholarship, Community Press, Other Deadlines Soon
- Treat-Your-Workers.org; International Coca-Cola Protest October 17
- Chinese AIDS Activist Released
- Nonoxynol-9 Dangers: Health Experts Warn Against Rectal Use
source: AIDS Treatment News
